Disclaimer: THE FOLLOWING CONTENT IS FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY (The content should not be considered or classified as professional financial, investment, trading, tax related, or legal advice/counseling. Trading any type of commodities, stocks, futures, options, and foreign currency, do have large risk/reward. Consult your financial experts for investment/trading advise.) ContraVir is a small #biotech
company focused on the research and development of vaccines for hepatitis B and “a fast-acting, low-dose, once-daily, oral antiviral therapy for the treatment of herpes zoster, or shingles, an infection caused by the reactivation of the varicella zoster (chicken pox) virus.” (source: https://contravir.com/valnivudine/). Shingles affect million of #person #world
wide, and it is severe on adults who were suffered with Chicken Pox when young. There are medications like Acyclovir or Famciclovir that are approved by the #FDA
to threat Shingles, however ContraVir product “Valnivudine™ has demonstrated an ability to reduce the incidence and severity of debilitating shingles-associated pain, known as post-herpetic neuralgia, or PHN.” (source: https://contravir.com/valnivudine/). Valnivudine is currently in phase-3.
Today we learned ContraVir is in collaboration with the Li Ka Shing Institute of Virology (LKSIoV), a researcher group from #Canada
that helped GlaxoSmithKline (GSK) to develop Shingrix (shingles vaccine) that it is approved by FDA. (source: https://globenewswire.com/news-release/2017/10/17/1148510/0/en/ContraVir-Pharmaceuticals-Announces-Research-Collaboration-Agreement-with-Li-Ka-Shing-Institute-of-Virology.html). Also, Contravir is proud sponsor of the 5th Private Wealth Latin America & the Caribbean Forum (Miami, October 17th and 18th) where banks like #BBVA, #Bradesco, #ITAU, #CITI
and others will be present.
I have attached a short technical analysis, at it seems there is a lot of potential in this stock both fundamental and technical approach.
Like and follow for more charts and #ideas.
#traders #traderlife #money #moneymaker #investment #usa #health #study #pharmacy #engineering #science #stock #trading